Helix BioMedix, Inc. (HXBM)

OTCMKTS · Delayed Price · Currency is USD
1.000
-0.700 (-41.18%)
At close: Mar 11, 2026
-86.07%
Market Cap 224.71K
Revenue (ttm) 2.07M
Net Income (ttm) -2.58M
Shares Out 224.71K
EPS (ttm) -15.59
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 201
Average Volume 255
Open 1.000
Previous Close 1.700
Day's Range 1.000 - 1.000
52-Week Range 1.000 - 6.450
Beta 0.83
RSI 19.54
Earnings Date n/a

About Helix BioMedix

Helix BioMedix, Inc., a biotechnology company, develops peptide-based therapeutics for dermatology and skin health in the United States. It is developing HB4208 for treatment of the rare disease Xeroderma Pigmentosum; and BIOACTIVE SMARTPEPTIDES, a bioactive peptide ingredient for skin care companies. The company was founded in 1988 and is based in Bothell, Washington. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1988
Employees 8
Stock Exchange OTCMKTS
Ticker Symbol HXBM
Full Company Profile

Financial Performance

In 2011, Helix BioMedix's revenue was $1.89 million, an increase of 122.07% compared to the previous year's $851,683. Losses were -$2.49 million, -67.73% less than in 2010.

News

There is no news available yet.